CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $10,790,000 | +2432.9% | 208,861 | +1114.3% | 0.39% | +3125.0% |
Q2 2022 | $426,000 | -36.8% | 17,200 | -7.0% | 0.01% | -29.4% |
Q4 2021 | $674,000 | +278.7% | 18,500 | +77.9% | 0.02% | +240.0% |
Q3 2021 | $178,000 | +3460.0% | 10,400 | +1721.4% | 0.01% | – |
Q2 2019 | $5,000 | -58.3% | 571 | -46.9% | 0.00% | -100.0% |
Q4 2018 | $12,000 | -14.3% | 1,076 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $14,000 | +7.7% | 1,076 | +9.5% | 0.00% | 0.0% |
Q1 2018 | $13,000 | +225.0% | 983 | +96.6% | 0.00% | – |
Q3 2017 | $4,000 | -73.3% | 500 | -68.8% | 0.00% | -100.0% |
Q2 2017 | $15,000 | +1400.0% | 1,600 | +700.0% | 0.00% | – |
Q1 2017 | $1,000 | -80.0% | 200 | -71.4% | 0.00% | -100.0% |
Q4 2016 | $5,000 | +66.7% | 700 | +32.3% | 0.00% | – |
Q3 2016 | $3,000 | -70.0% | 529 | -70.9% | 0.00% | -100.0% |
Q3 2013 | $10,000 | – | 1,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |